Efficacy of the CLP® Hip - Retrospective

NCT00764842 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2011-02-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.

Conditions

Interventions

DEVICE

Encore CLP® Hip stem

Subjects with osteoarthritis, rheumatoid arthritis or avascular necrosis of the natural femoral head who have received the Encore CLP® Hip stem and are willing to participate in the study.

Sponsors & Collaborators

  • Encore Medical, L.P.

    lead INDUSTRY

Principal Investigators

  • D. Kevin Lester, M.D. · Center for Excellence

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00764842 on ClinicalTrials.gov